Work Package 6: Economic Effectiveness
Work package 6 has the following objectives:
1. Estimate costs and health benefits associated with the interventions, including estimation of quality of life impact of infections.
2. Perform cost-effectiveness evaluations accounting for heterogeneity based on the clinical trial results.
3. Perform cost-effectiveness evaluations beyond the trial duration incorporating the impact on resistance and its health and cost consequences in the long term.
4. Conduct budget-impact analyses to provide estimates of affordability of tested interventions in different resource settings.
5. Identify potential barriers and facilitators of implementation in two selected low-and-middle-income countries.
Leading Partner
Other Partners Involved
Relevant Publications
-
Pollard, J., Graves, N., Whitby, M., & Barnett, A. G. (2024). Umbrella review of economic evaluations of interventions for the prevention and management of healthcare-associated infections in adult hospital patients. Journal of Hospital Infection, 158, 47–60.
Publication date: 19 March 2025
Authors: J. Pollard, E. Agnew, N. Pearce-Smith, K.B. Pouwels, N. Salant, J.V. Robotham, and the REVERSE Consortium
Journal: The Journal of Hospital Infection
Title: Umbrella review of economic evaluations of interventions for the prevention and management of healthcare-associated infections in adult hospital patients
Abstract:
Link(s): https://www.journalofhospitalinfection.com/article/S0195-6701(25)00009-X/fullte…
File(s): Umbrella Review
SUBSCRIBE TO REVERSE NEWS
By filling this form you consent to receiving the REVERSE Newsletter. For more information read our privacy & cookies policy.
CONNECT WITH US